Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience.
Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience. Front Immunol. 2022; 13:864545.
View in:
PubMed
subject areas
Aged
Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Epstein-Barr Virus Infections
Herpesvirus 4, Human
Humans
Immunosuppressive Agents
Kidney Transplantation
Lung Transplantation
Retrospective Studies
authors with profiles
Pablo Sanchez
Ernest Chan